brainstorm cell therapeutics: Live & Latest News Updates : Vimarsana.com

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Short Interest Update

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI – Get Free Report) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 1,990,000 shares, an increase of 48.5% from the March 31st total of 1,340,000 shares. Based on an average daily volume of 987,100 shares, the short-interest […]

Securities-exchange-commission
Brainstorm-cell-therapeutics-inc
Nasdaq
Kingswood-wealth-advisors
Brainstorm-cell-therapeutics
Get-free-report
Cell-therapeutics
Brainstorm-cell
Wealth-advisors
Free-report
Cell-therapeutics-inc

Recursion, Canaan, Metsera and more—Chutes & Ladders

Recursion, Canaan, Metsera and more—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

London
City-of
United-kingdom
Italy
Utah
United-states
Italian
British
Le-goff
Cytosite-biopharma
Najat-khan
Corinne-le-goff

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS

BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University-of-california-irvine
California
United-states
Massachusetts
University-of-massachusetts
Lisa-guiterman
Anthonyj-windebank
Stacy-lindborg
Robertj-manning
Michael-wood
Julieanne-doran
Jean-pape-adams

Brainstorm Cell Therapeutics (BCLI) Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

Brainstorm Cell Therapeutics (BCLI) Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Stacy-lindborg
Chaim-lebovits
Data-monitoring-committee
Drug-administration
Nasdaq
Brainstorm-cell-therapeutics-inc
Brainstorm-cell-therapeutics
Special-protocol-assessment
Biologics-license-application
Chief-executive-officer
Institutional-review-board

After knock back, BrainStorm aligns with FDA on ph. 3 ALS trial

After knock back, BrainStorm aligns with FDA on ph. 3 ALS trial
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Chaim-lebovits
Brainstorm-cell-therapeutics

Tiny brain bubbles carry complete codes

Tiny brain bubbles carry complete codes
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Carterr-palmer
Neurocrine-biosciences
Jerold-chun
Juliet-nicodemus
Christines-liu
Sanford-burnham-prebys
Derya-ziomek
Emily-dunsmore
Abbott-abbvie
Research-at-sanford-burnham-prebys
Janssen-research
National-institute

Amylyx to pull failed ALS drug from market, cut 70% of staff

Amylyx to pull failed ALS drug from market, cut 70% of staff
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Canada
Phoenix
Arizona
United-states
Massachusetts
American
Tanabe-pharma
Justin-klee
Amylyx-pharmaceuticals
American-academy-of-neurology
Mitsubishi-tanabe-pharma
Ionis-pharmaceutical-qalsody

BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update

Conference call planned for early April 2024 to provide update on NurOwn program NEW YORK, April 1, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell...

California
United-states
Stacy-lindborg
Chaim-lebovits
Lisa-guiterman
Michael-wood
Research-symposium
Drug-administration
European-medicines-agency
California-institute-for-regenerative-medicine
Nasdaq
National-ms-society

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Sees Large Decline in Short Interest

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Sees Large Decline in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Topco-ltd
Renaissance-technologies
Nasdaq
Brainstorm-cell-therapeutics-inc
Tower-research-capital
Brainstorm-cell-therapeutics
Get-free-report
Cell-therapeutics
Research-capital
Street-group
Cell-therapeutics-inc

Pharma Co. Brass Overhyped ALS Drug Efficacy, Suit Says

Executives and directors of neurodegenerative disease drugmaker Brainstorm Cell Therapeutics have been hit with a proposed class action alleging they damaged the company by overstating the effectiveness of its Lou Gehrig's disease drug even after the U.S. Food and Drug Administration rejected its license application.

Sydney
New-south-wales
Australia
Lou-gehrig
Drug-administration
Sydney-price
Brainstorm-cell-therapeutics